EVOKE PHARMA INC (EVOK) Stock Cash Flow
NASDAQ:EVOK - Nasdaq - US30049G3020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.08M | -5.35M | -7.79M | -8.22M | -8.54M | |||
| Change In Working Capital | 566.30K | -892.40K | 1.55M | 130.00K | -5.62M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 635.40K | 785.90K | 1.26M | 1.50M | 1.80M | |||
| OPERATING CASH FLOW | -3.88M | -5.46M | -4.99M | -6.60M | -12.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 6.80M | 14.74M | 0.00 | 7.44M | 13.43M | |||
| Other Financing Activity | N/A | -426.30K | -119.30K | -150.00K | N/A | |||
| FINANCING CASH FLOW | 6.80M | 14.32M | -119.30K | 7.29M | 13.43M | |||
| CHANGE IN CASH | 2.92M | 8.86M | -5.10M | 700.00K | 1.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.88M | -5.46M | -4.99M | -6.60M | -12.35M | |||
| FREE CASH FLOW | -3.88M | -5.46M | -4.99M | -6.60M | -12.35M | |||
All data in USD